A carregar...

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety

Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity of migraine. It affects 0.9%–2.2% of the general adult population. The present paper overviews the preclinical and clinical data regarding the therapeutic effect of onabotulinumtoxinA in chronic migrai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Toxins (Basel)
Main Authors: Szok, Délia, Csáti, Anett, Vécsei, László, Tajti, János
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516935/
https://ncbi.nlm.nih.gov/pubmed/26193319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins7072659
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!